{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:59:18Z","timestamp":1778853558794,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T00:00:00Z","timestamp":1380326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2458-13-894","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T23:35:27Z","timestamp":1380324927000},"source":"Crossref","is-referenced-by-count":19,"title":["House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study"],"prefix":"10.1186","volume":"13","author":[{"given":"Alicia H","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Polesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulshan","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,28]]},"reference":[{"key":"5842_CR1","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection: American thoracic society. MMWR Recomm Rep. 2000, 49 (RR-6): 1-51."},{"key":"5842_CR2","first-page":"28","volume":"26","author":"SH Ferebee","year":"1970","unstructured":"Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibliotheca tuberculosea. 1970, 26: 28-106.","journal-title":"Bibliotheca tuberculosea"},{"key":"5842_CR3","unstructured":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial: international union against tuberculosis committee on prophylaxis. Bull World Health Organ. 1982, 60 (4): 555-564."},{"issue":"10","key":"5842_CR4","first-page":"847","volume":"3","author":"GW Comstock","year":"1999","unstructured":"Comstock GW: How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 1999, 3 (10): 847-850.","journal-title":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"5842_CR5","unstructured":"Healthy people 2010, vol. two, second edn. 2000, Washington DC, USA: US Department of Health and Human Services"},{"issue":"11","key":"5842_CR6","first-page":"1235","volume":"12","author":"Y Hirsch-Moverman","year":"2008","unstructured":"Hirsch-Moverman Y, Daftary A, Franks J, Colson PW: Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008, 12 (11): 1235-1254.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"5842_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh","year":"2010","unstructured":"Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, et al: Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010, 137 (2): 401-409. 10.1378\/chest.09-0394.","journal-title":"Chest"},{"key":"5842_CR8","first-page":"83","volume":"8","author":"JP Tulsky","year":"2004","unstructured":"Tulsky JP, Hahn JA, Long HL, Chambers DB, Robertson MJ, Chesney MA, Moss AR: Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis. 2004, 8: 83-91.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"17","key":"5842_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.2146\/ajhp090034","volume":"66","author":"JP Last","year":"2009","unstructured":"Last JP, Kozakiewicz JM: Development of a pharmacist-managed latent tuberculosis clinic. Am J Health Syst Pharm. 2009, 66 (17): 1522-1523. 10.2146\/ajhp090034.","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"5842_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archinte.162.9.1044","volume":"162","author":"MC White","year":"2002","unstructured":"White MC, Tulsky JP, Goldenson J, Portillo CJ, Kawamura M, Menendez E: Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail. Arch Intern Med. 2002, 162 (9): 1044-1050. 10.1001\/archinte.162.9.1044.","journal-title":"Arch Intern Med"},{"issue":"8","key":"5842_CR11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, et al: An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006, 174 (8): 935-952. 10.1164\/rccm.200510-1666ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"5842_CR12","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF: What\u2019s The relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA: the journal of the American Medical Association. 1998, 280 (19): 1690-1691. 10.1001\/jama.280.19.1690.","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"8","key":"5842_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/oxfordjournals.aje.a009523","volume":"147","author":"LE Daly","year":"1998","unstructured":"Daly LE: Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1998, 147 (8): 783-790. 10.1093\/oxfordjournals.aje.a009523.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"5842_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","volume":"75","author":"Y Hochberg","year":"1988","unstructured":"Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988, 75 (4): 800-802. 10.1093\/biomet\/75.4.800.","journal-title":"Biometrika"},{"issue":"19","key":"5842_CR15","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1001\/jama.1986.03380190079029","volume":"256","author":"DN Rose","year":"1986","unstructured":"Rose DN, Schechter CB, Silver AL: The age threshold for isoniazid chemoprophylaxis: a decision analysis for low-risk tuberculin reactors. JAMA: the journal of the American Medical Association. 1986, 256 (19): 2709-2713. 10.1001\/jama.1986.03380190079029.","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"3","key":"5842_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1086\/600394","volume":"49","author":"H Young","year":"2009","unstructured":"Young H, Wessolossky M, Ellis J, Kaminski M, Daly JS: A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in Central Massachusetts. Clin Infect Dis. 2009, 49 (3): 424-427. 10.1086\/600394.","journal-title":"Clin Infect Dis"},{"issue":"17","key":"5842_CR17","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","volume":"166","author":"KR Page","year":"2006","unstructured":"Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, et al: Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Arch Intern Med. 2006, 166 (17): 1863-1870. 10.1001\/archinte.166.17.1863.","journal-title":"Arch Intern Med"},{"issue":"11","key":"5842_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","volume":"179","author":"DP Holland","year":"2009","unstructured":"Holland DP, Sanders GD, Hamilton CD, Stout JE: Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med. 2009, 179 (11): 1055-1060. 10.1164\/rccm.200901-0153OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"5842_CR19","first-page":"257","volume":"133","author":"D Menzies","year":"2011","unstructured":"Menzies D, Al Jahdali H, Al Otaibi B: Recent developments in treatment of latent tuberculosis infection. Indian J Med Res. 2011, 133: 257-266.","journal-title":"Indian J Med Res"},{"issue":"23","key":"5842_CR20","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, et al: Three months of rifapentine and isoniazid for latent tuberculosis infection. The New England journal of medicine. 2011, 365 (23): 2155-2166. 10.1056\/NEJMoa1104875.","journal-title":"The New England journal of medicine"},{"issue":"1","key":"5842_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1005136","volume":"365","author":"NA Martinson","year":"2011","unstructured":"Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE: New regimens to prevent tuberculosis in adults with HIV infection. The New England journal of medicine. 2011, 365 (1): 11-20. 10.1056\/NEJMoa1005136.","journal-title":"The New England journal of medicine"},{"key":"5842_CR22","unstructured":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection. Morbidity and mortality weekly report. 2011, 60 (48): 1650-1653."},{"issue":"7","key":"5842_CR23","doi-asserted-by":"publisher","first-page":"e22276","DOI":"10.1371\/journal.pone.0022276","volume":"6","author":"D Holland","year":"2011","unstructured":"Holland D, Sanders G, Hamilton C, Stout J: Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection. PLoS ONE. 2011, 6 (7): e22276-e22276. 10.1371\/journal.pone.0022276.","journal-title":"PLoS ONE"},{"issue":"6","key":"5842_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0213-005X(03)72943-7","volume":"21","author":"J Portilla","year":"2003","unstructured":"Portilla J, Jorda P, Esteban J, Sanchez-Paya J, Merino E, Boix V, Grupo de Estudio Protocolo INH: Directly observed treatment of latent tuberculosis infection: comparative study of two isoniazid regimens. Enfermedades infecciosas y microbiologia clinica. 2003, 21 (6): 293-295.","journal-title":"Enfermedades infecciosas y microbiologia clinica"},{"issue":"5","key":"5842_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1177\/1359105307080618","volume":"12","author":"A Schumann","year":"2007","unstructured":"Schumann A, Nyamathi A, Stein JA: HIV risk reduction in a nurse case-managed TB and HIV intervention among homeless adults. J Health Psychol. 2007, 12 (5): 833-843. 10.1177\/1359105307080618.","journal-title":"J Health Psychol"},{"issue":"1","key":"5842_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.NNR.0000280660.26879.38","volume":"57","author":"A Nyamathi","year":"2008","unstructured":"Nyamathi A, Nahid P, Berg J, Burrage J, Christiani A, Aqtash S, Morisky D, Leake B: Efficacy of nurse case-managed intervention for latent tuberculosis among homeless subsamples. [Article]. Nurs Res. 2008, 57 (1): 33-39. 10.1097\/01.NNR.0000280660.26879.38.","journal-title":"Nurs Res"},{"issue":"11","key":"5842_CR27","doi-asserted-by":"publisher","first-page":"e48900","DOI":"10.1371\/journal.pone.0048900","volume":"7","author":"C Dobler","year":"2012","unstructured":"Dobler C, Marks G: Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic. PLoS ONE. 2012, 7 (11): e48900-e48900. 10.1371\/journal.pone.0048900.","journal-title":"PLoS ONE"},{"issue":"11","key":"5842_CR28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","volume":"281","author":"CM Nolan","year":"1999","unstructured":"Nolan CM, Goldberg SV, Buskin SE: Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA : the journal of the American Medical Association. 1999, 281 (11): 1014-1018. 10.1001\/jama.281.11.1014.","journal-title":"JAMA : the journal of the American Medical Association"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-13-894\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T04:12:32Z","timestamp":1468469552000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-13-894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["5842"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-13-894","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,28]]},"article-number":"894"}}